[Elsevier]
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Authors: Arango C, Buitelaar JK, Fegert JM, et al.
Title: Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Journal: Lancet Psychiatry, 9(2):113-124 (2022)
DOI: 10.1016/S2215-0366(21)00390-4
https://doi.org/10.1016/S2215-0366(21)00390-4